In a major step toward integrating Artificial Intelligence into healthcare, Apollo Hospitals in Madurai has fully ...
Wrist pulse oximeters can look similar, making it hard to decide which one to buy. This in-depth guide covers everything you need to know to find your best fit.
Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...
Danaher Corporation (NYSE:DHR) is one of the best non-tech stocks to buy according to analysts. Masimo, Danaher Corporation’s ...
Discover the latest on Apple’s revolutionary smart ring, including features and rumored release dates, in our comprehensive guide. Stay updated now.
On 22 June 2026, Masimo, a Danaher company, received FDA 510(k) clearance for an AI-enabled opioid-induced respiratory ...
"Masimo secures FDA approval for OIRD detection on wearable patient monitor" was originally created and published by Medical ...
The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...
Shweta Ganjoo is a Chief Content Producer at HT Tech. She has over 10 years of experience covering technology, during which time she has focused on consumer tech devices, AI, social media, gadgets, ...
This popular CGM can now be marketed for children 2 years of age and older who do not use insulin. Anna Gragert Senior Editor, Health and Home Anna Gragert (she/her/hers) was previously the lifestyle ...
Share on Pinterest The FDA approved the first nonprescription sale of Dexcom’s continuous glucose monitor for children ages 2 to 18 with diabetes. Svetikd/Getty Images The Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results